Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome

Clinical trial NCT00266565 · COMPLETED

Trial details

NCT number: NCT00266565
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hypereosinophilic Syndromes Eosinophilic Gastroenteritis Churg-Strauss Syndrome Eosinophilic Esophagitis

Start date: 2001-12-01
Primary completion: 2005-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.